New advances in retina: a report from the International Symposium on Ocular Pharmacology and Therapeutics meeting

Abstract

In its tenth year, the International Symposium on Ocular Pharmacology and Therapeutics meeting, was held in Paris, France, on 7–10 March 2013. The conference was an update of clinical and basic research in ophthalmology. The exciting program and lively discussions of the key issues in major ophthalmic indications provided a chance for retina specialists to share their experience and knowledge.

The 10th International Symposium on Ocular Pharmacology and TherapeuticsParis, France7–10 March 2013

Financial & competing interests disclosure

P Lanzetta is a consultant for Alimera, Bayer, Roche and Novartis Pharma AG. He has a patent with Iridex Co. and has received honoraria or travel reimbursement from Allergan and Novartis Pharma AG. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.